查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1922991

全球患者体内给药系统市场（按给药方式、产品类型、技术、应用和最终用户划分）预测（2026-2032 年）

Over Patient Delivery System Market by Delivery Mode, Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，海外病人输送系统市场价值将达到 12.2 亿美元，到 2026 年将成长到 13 亿美元，到 2032 年将达到 20.1 亿美元，年复合成长率为 7.36%。

主要市场统计数据
基准年 2025 12.2亿美元
预计年份：2026年 13亿美元
预测年份：2032年 20.1亿美元
复合年增长率 (%) 7.36%

针对病患转运系统的全面策略指南：重点关注营运影响、临床整合需求以及相关人员的实用决策标准

本执行摘要为现代患者照护服务系统提供策略指南，整合了影响临床实施和采购决策的营运、技术和监管因素。它阐述了医院管理者、医疗设备製造商、支付方和创新团队在评估影响病人安全、护理效率和护理连续性的设备和专案时必须应对的关键挑战。它重点阐述了不断变化的护理环境、患者期望和设备互通性如何相互交织，从而重新定义整个护理过程中的价值提案。

技术、临床和监管方面的变革正在重新定义患者照护服务体系，并提高了诚信、安全和真实世界证据的标准。

以病患为导向的医疗设备系统格局正经历根本性的变革，其驱动力来自于科技的融合、医疗服务模式的转变以及日益增长的安全期望。小型化、感测器整合和互联互通技术的进步，催生了新一代医疗设备，它们不再局限于单一功能硬件，而是成为可互通临床生态系统的组成部分。随着医疗系统寻求能够减轻医护人员负担、同时提高剂量、依从性和不利事件检测数据准确性的医疗设备，这种变革正在影响采购重点。

2025 年美国关税的累积影响将改变病患输送系统的采购、设计重点和总成本考量。

2025年美国关税的累积影响已对整个医疗服务供应链的营运和策略层面产生了显着影响。关税措施提高了某些进口零件和成品的本地到货成本，迫使製造商和医疗系统重新评估其筹资策略、零件替代方案和库存管理实践。为此，采购部门正在加快供应商多元化进程，并加强合约谈判，以在确保产品品质和合规性的同时降低风险。

深入了解给药方式、产品类型、终端用户环境、核心技术和临床应用领域，以指导策略性产品和商业性选择。

深入的市场细分揭示了临床需求、使用者行为和技术之间的交集，从而在给药方式、产品类型、最终用户、技术和应用方面创造差异化价值。基于给药方式，市场研究框架将系统分为自动化系统和手动系统。自动化解决方案进一步细分为大剂量投药、连续式和间歇式给药模式，而手动方案则以重力供液和挤压式给药为特征。这些区分至关重要，因为自动化方案往往侧重于封闭回路型控制、持续给药和资料收集，而手动方案由于其简便性和低维护成本，在资源匮乏的环境或需要快速回应的情况下仍然被广泛采用。

区域采用模式和策略意义（美洲、欧洲、中东和非洲、亚太地区）正在影响商业化和产品组合决策。

区域趋势影响着病患服务体系的采用管道、监管预期和供应链配置。领导者必须解读区域讯号，并调整产品设计和打入市场策略。在美洲，医疗系统正增加对数位整合和上市后证据收集的投资，因此越来越倾向于选择具备连接性、数据分析和清晰临床性能指标的设备。人口结构变化和成本控制压力也推动了该地区对支持门诊和居家护理解决方案的兴趣。

医疗设备製造商与技术专家之间的竞争与合作趋势凸显了策略性收购对互联互通、卓越服务和差异化发展的影响。

领先的医疗设备製造商和技术提供者之间的竞争动态表明，他们在连接性、以用户为中心的设计和循证医学方面的优先事项趋于一致。拥有强大工程能力和完善售后服务的公司正赢得大型医疗系统采购部门的更多信任，这些部门将可维护性和供应商应对力视为设备整体性能的关键因素。此外，那些早期投资于安全连接和云端分析的製造商，在展示设备长期性能和临床医生日益关注的依从性指标方面，也拥有竞争优势。

针对製造商和医疗保健系统，提出以互通性、人体工学、消毒通讯协定和供应链弹性为重点的具体策略建议。

产业领导者应优先考虑互通性和供应链韧性，将其视为保持竞争优势和临床可靠性的当务之急。在设备架构中建立标准化的连接和开放API有助于与电子健康记录（EHR）和远端监测平台集成，最终促进临床医生采用并随着时间的推移收集更多证据。除了技术整合之外，重点投资于人体工学测试和简化使用者介面，将减轻培训负担，并降低非专业环境下使用者出错的风险。

采用透明的多方法调查方法，结合专家访谈、设备技术评估和工作流程分析，以获得可操作的营运洞察。

我们的研究途径结合了定性专家访谈、设备层面的技术评估和跨职能工作流程分析，以三角验证的方式深入了解技术性能和应用障碍。主要研究包括与临床医生、生物医学工程师、采购人员和受过培训的看护者进行结构化讨论，以发现操作挑战并检验设备在实际临床场景下的可用性。此外，我们还对设备规格、灭菌要求和材料相容性进行了技术审查，以评估其对再处理和生命週期管理的影响。

摘要强调，高度互通性和人性化的交付系统对于实现临床价值至关重要，而支持性证据和供应链韧性也至关重要。

总之，病患输送系统融合了设备工程、临床工作流程设计和医疗系统运作策略。智慧技术的整合、不断变化的医疗环境以及日益严格的监管要求，正在重新定义采购者最为重视的属性：互联性、易用性、清晰的再处理流程以及可验证的临床疗效。那些能够将产品设计与实际临床工作流程相契合、建立稳健的供应链并以上市后证据支持其主张的机构，将更有利于在各种医疗环境中实现持续推广应用。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依给药方式分類的过量病患给药系统市场

  • 自动的
    • Bolus
    • 执着的
    • 间歇性
  • 手动的
    • 重力
    • 推

9. 依产品类型分類的超负荷病人输送系统市场

  • 一次性
    • 塑胶
    • 硅
  • 可重复使用的
    • 高压釜
    • 不可高压釜

第十章 按技术分類的超患者输送系统市场

  • 贴片帮浦
    • 免洗片
    • 可重复使用的补丁
  • 管子
    • PVC
    • 硅
  • 穿戴式装置
    • 非智慧型穿戴装置
    • 智慧型穿戴装置

第十一章 按应用分類的过量患者输送系统市场

  • 麻醉
  • 点滴
  • 疼痛管理

第十二章 依最终用户分類的超额病人输送系统市场

  • 诊所
  • 居家照护
    • 患者自我给药
    • 护理机构
  • 医院
    • 紧急状况
    • 普通病房
    • 加护病房

第十三章 区域性病患配送系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 按组别分類的超重患者输送系统市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国超额病患输送系统市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国超重病人运输系统市场

第十七章：中国超重病患交付系统市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acteon Group
  • Anthos srl
  • Being Foshan Medical Equipment Co., Ltd.
  • Chirana Holding as
  • Cingolani Srl
  • Confident Dental Equipment Pvt. Ltd.
  • Dentsply Sirona Inc.
  • Diplomat Dental sro
  • Flight Dental Systems
  • Forest Dental Products, Inc.
  • Gnatus International Ltda.
  • Hican SA
  • KaVo Dental GmbH
  • Marus Dental International
  • Mestra Talleres SL
  • Midmark Corporation
  • Planmeca Oy
  • Ritter Concept GmbH
  • Stern Weber srl
  • Takara Belmont Corporation
  • United Medical Equipment Co., Ltd.
  • Yoshida Dental Mfg. Co., Ltd.
Product Code: MRR-867BED9A9EA9

The Over Patient Delivery System Market was valued at USD 1.22 billion in 2025 and is projected to grow to USD 1.30 billion in 2026, with a CAGR of 7.36%, reaching USD 2.01 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.22 billion
Estimated Year [2026] USD 1.30 billion
Forecast Year [2032] USD 2.01 billion
CAGR (%) 7.36%

A comprehensive strategic orientation to patient delivery systems highlighting operational impacts, clinical integration needs, and practical decision criteria for stakeholders

This executive summary provides a strategic orientation to contemporary patient delivery systems, synthesizing the operational, technological, and regulatory factors shaping clinical adoption and procurement decisions. It frames the critical questions that hospital administrators, device manufacturers, payers, and innovation teams must address when evaluating devices and programs that influence patient safety, care efficiency, and the continuity of therapy. The narrative emphasizes how changes in care settings, patient expectations, and device interoperability are intersecting to redefine value propositions across the care continuum.

The introduction focuses on the urgent operational pressures and strategic opportunities that characterize the current landscape. As health systems prioritize capacity optimization and whole-person care, the functional performance of delivery systems-including reliability, ease of use, and integration with digital health platforms-has emerged as a decisive factor in clinical selection and training investments. Consequently, leaders must evaluate delivery technologies not only on device-level specifications but also on lifecycle considerations such as sterilization protocols, compatibility with electronic health records, and the degree to which devices support decentralized care models.

Beyond procurement and clinical choice, the introduction also outlines methodological boundaries for the report and what readers should expect in subsequent sections. It clarifies that the emphasis is on operational impact, clinical workflow integration, and technology-driven enhancements rather than on financial forecasting, thereby equipping executives with practical insights for near- and mid-term strategic planning. The summary establishes a common framework for interpreting the more detailed analyses that follow and highlights the importance of cross-functional alignment among clinical, supply chain, and digital teams when implementing new delivery-system solutions.

Transformative technological, clinical, and regulatory shifts are redefining patient delivery systems and raising the bar for integration, safety, and real-world evidence

The patient delivery system landscape is undergoing foundational shifts driven by technology convergence, changing care delivery models, and elevated safety expectations. Advances in miniaturization, sensor integration, and connectivity have enabled a new generation of devices that move beyond single-function hardware to become nodes in an interoperable clinical ecosystem. This evolution is influencing procurement priorities as health systems seek devices that reduce clinician burden while increasing data fidelity for dosing, adherence, and adverse event detection.

Concurrently, care is migrating across traditional institutional boundaries. More therapies once confined to inpatient wards are being delivered in ambulatory clinics and in patients' homes, requiring devices designed for non-specialist use and for environments that lack centralized sterilization and asset management resources. These shifts are accelerating demand for designs that prioritize intuitive operation, simplified maintenance, and clear custodial responsibilities, as well as for training programs that can be scaled for care teams and patient caregivers alike.

Regulatory rigor and reimbursement dynamics are also reshaping device development pathways. Regulators are placing greater emphasis on risk-based approaches, human factors engineering, and post-market surveillance data. Payers and providers, in turn, are examining how device-related outcomes contribute to value-based care metrics such as readmissions, adverse events, and therapy adherence. As a result, manufacturers are increasingly required to demonstrate real-world performance and to provide evidence of how their systems affect clinical workflows and downstream resource utilization.

Finally, the rise of smart wearables and edge-computing capabilities is expanding the role of delivery systems from passive conduits to active caregivers that can adapt dosing or notify clinicians based on sensed physiologic changes. This transition amplifies both opportunity and complexity: device software, cybersecurity, and data governance become central to product differentiation and to the trust clinicians place in these technologies. Taken together, these transformative shifts are setting a higher bar for design, clinician training, and cross-stakeholder collaboration.

How the cumulative effects of United States tariff measures in 2025 are reshaping sourcing, design priorities, and total cost considerations for patient delivery systems

The cumulative impact of United States tariffs implemented in 2025 has introduced distinct operational and strategic consequences across the supply chain for patient delivery systems. Tariff policies have increased landed costs for specific imported components and finished devices, prompting manufacturers and health systems to re-evaluate sourcing strategies, component substitution, and inventory practices. In response, procurement teams have accelerated supplier diversification and intensified contract negotiations to mitigate exposure while maintaining product quality and regulatory consistency.

Manufacturers that rely on globalized production footprints have confronted the need to reassess their manufacturing network resiliency. Some have begun selective nearshoring of assembly or critical subassembly operations to stabilize input costs and reduce lead-time variability. This realignment has required investments in local compliance, workforce training, and quality infrastructure, and has sometimes lengthened product development timelines due to the need to qualify alternative suppliers under medical device regulatory frameworks.

The tariff environment has also intensified interest in design choices that reduce dependency on tariffed inputs. For instance, product engineering teams are prioritizing material substitutions, greater modularity, and enhanced compatibility with domestically sourced tubing, connectors, and sensor modules. In parallel, supply chain teams are placing a renewed emphasis on transparency, mapping multi-tier suppliers, and stress-testing alternative logistical routes to anticipate disruption.

For health system purchasers, the tariff-driven cost inflation has sharpened scrutiny of total cost of ownership and device lifecycle costs, rather than upfront price alone. Decisions increasingly hinge on comparative durability, ease of sterilization, and serviceability. Importantly, the tariff environment has catalyzed closer collaboration between clinical purchasers and engineering teams to ensure that procurement choices do not inadvertently compromise clinical performance or patient safety. Overall, tariffs have acted as a catalyst for structural changes in sourcing, product design, and procurement governance that will persist beyond immediate policy cycles.

Deep segmentation-driven insights across delivery mode, product type, end-user environments, core technologies, and clinical applications to guide strategic product and commercial choices

Insightful segmentation reveals where clinical need, user behavior, and technology intersect to create differentiated value across delivery modes, product types, end users, technologies, and applications. Based on Delivery Mode, market study frameworks distinguish Automated systems from Manual systems; Automated solutions further categorize into Bolus, Continuous, and Intermittent modalities, while Manual options are characterized by Gravity and Push approaches. These distinctions matter because automated implementations tend to emphasize closed-loop control, consistent dosing, and data capture, whereas manual approaches remain prevalent in low-resource or rapid-response contexts due to their simplicity and low-maintenance profiles.

Based on Product Type, devices are considered across Disposable and Reusable classes; the Disposable class includes Plastic and Silicone variants, and the Reusable class includes Autoclavable and Nonautoclavable options. Disposable plastic and silicone designs are often optimized for single-patient use and infection control, delivering operational simplicity for settings with constrained sterilization workflows. Reusable autoclave-compatible devices appeal to systems focused on lifecycle cost management and robust sterilization protocols, while nonautoclavable reusables require clearly defined cleaning protocols and may serve specialized clinical niches.

Based on End User, segmentation includes Clinics, Home Care, and Hospitals; Home Care is further parsed into Patient Self-Administered and Skilled Nursing use cases, while Hospitals are further segmented into Emergency, General Ward, and ICU environments. Each end-user category imposes different design and support requirements: clinics require compact, portable systems that support throughput; home care demands intuitive interfaces and caregiver assistance features; hospitals prioritize rapid response capability, interoperability with clinical monitoring systems, and durability under frequent reprocessing. The ICU context, in particular, places a premium on integration with hemodynamic monitoring and alarm management systems.

Based on Technology, analysis differentiates Patch Pump, Tubing, and Wearable solutions; the Patch Pump category is subdivided into Disposable Patch and Reusable Patch designs, Tubing is evaluated across PVC and Silicone constructions, and Wearable devices are differentiated between Non-Smart Wearable and Smart Wearable offerings. Patch pumps and wearable systems have emerged as important enablers of ambulatory and home-based therapy, with smart wearables adding telemetric capabilities and adherence analytics. Tubing material choices affect chemical compatibility, kinking resistance, and sterilization pathways and therefore influence clinical preference and supply chain planning.

Based on Application, the focus spans Anesthesia, Infusion, and Pain Management. Application-specific requirements influence dosing precision, programmability, and alarm logic. Anesthesia contexts demand rapid response and seamless integration with perioperative workflows, infusion contexts emphasize long-duration accuracy and compatibility with various therapeutic agents, and pain management applications prioritize patient comfort, simplified user controls, and adherence monitoring to prevent misuse. Integrating these segmentation lenses reveals where incremental innovation will yield the greatest operational and clinical returns and where commercialization strategies can be aligned with end-user pain points.

Regional adoption patterns and strategic implications across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping commercialization and product configuration decisions

Regional dynamics shape adoption pathways, regulatory expectations, and supply chain configurations for patient delivery systems, and leaders must interpret regional signals to align product design and market entry strategies. In the Americas, health systems are intensifying investments in digital integration and post-market evidence collection; as a consequence, devices that offer connectivity, data analytics, and clear clinical performance metrics are increasingly favored. This region also shows pronounced interest in solutions that support outpatient and home-based therapy due to demographic trends and cost containment pressures.

In Europe, the Middle East & Africa, regulatory heterogeneity and varying levels of healthcare infrastructure create a mosaic of adoption conditions. Reimbursement frameworks and centralized procurement in parts of Europe encourage rigorous clinical evidence and lifecycle cost justification, while emerging markets in the Middle East & Africa often prioritize durability, ease of maintenance, and supply-chain robustness. Manufacturers seeking traction in this broad region must balance localized regulatory strategies with product configurations that are adaptable to disparate clinical practice patterns.

In the Asia-Pacific region, rapid capacity expansion, growing domestic manufacturing capability, and an expanding ambulatory care footprint are driving demand for scalable, cost-efficient delivery systems. Local players in several countries have advanced capabilities in component manufacturing and assembly, which creates competitive dynamics that favor cost-effective innovation and rapid iteration. Cross-border partnerships and regional distribution networks are therefore critical for companies aiming to scale, and alignment with local clinical workflows and language localization for user interfaces is a recurring success factor.

Across all regions, differences in sterilization infrastructure, clinical workforce training capacity, and procurement governance will continue to determine how quickly new device classes are adopted. Successful market strategies will pair regional regulatory navigation with targeted investments in training, service networks, and evidence generation tailored to the specific expectations of healthcare purchasers in each geography.

Competitive and partnership dynamics among device makers and technology specialists highlighting connectivity, service excellence, and strategic acquisitions driving differentiation

Competitive dynamics among leading device manufacturers and technology providers reveal convergent priorities around connectivity, user-centered design, and evidence generation. Companies that combine robust engineering with comprehensive post-sale service capabilities command greater trust among large health system purchasers who view serviceability and vendor responsiveness as critical components of total device performance. In addition, manufacturers that have invested early in secure connectivity and cloud-based analytics have a competitive advantage in demonstrating longitudinal device performance and adherence metrics that clinicians increasingly require.

Strategic partnerships and selective acquisitions are common tactics as firms seek to augment software capabilities, telemedicine integration, and advanced sensor portfolios. These moves enable faster entry into emerging product categories such as smart wearables and patch pumps while leveraging established distribution networks to accelerate clinical trials and post-market surveillance efforts. At the same time, some incumbents are responding to new entrants by reimagining their service models to include training-as-a-service and device-as-a-service propositions that can reduce upfront capital barriers for hospitals and clinics.

Newer entrants and smaller specialists that excel in a narrow technological domain-whether in microfluidics, secure embedded software, or novel materials-are influencing product roadmaps across the industry by demonstrating focused clinical benefits and niche adoption pathways. Their agility often forces larger firms to experiment with modular product designs and faster iterative cycles. Overall, success in the competitive landscape requires a balanced strategy that marries product differentiation with operational excellence in manufacturing, regulatory compliance, and after-sales service.

Actionable strategic recommendations for manufacturers and health systems focusing on interoperability, human factors, sterilization protocols, and supply chain resilience

Industry leaders should prioritize interoperability, human factors engineering, and supply chain resilience as immediate levers to sustain competitive advantage and clinical credibility. Embedding standardized connectivity and open APIs into device architectures will ease integration with electronic health records and remote monitoring platforms, which in turn supports clinician adoption and longitudinal evidence collection. Alongside technical integration, focused investment in human factors testing and simplified user interfaces will reduce training overhead and lower the risk of user error in non-specialist settings.

Manufacturers and health systems should co-develop sterilization and reprocessing protocols early in the design cycle to avoid downstream operational friction. Clear, field-validated cleaning procedures and service manuals will accelerate hospital credentialing and enable broader use in clinics and home-care environments. Additionally, firms should evaluate nearshoring options for critical components and build multi-tier supplier redundancy to buffer against tariff-induced cost volatility and geopolitical disruption.

To strengthen market positioning, companies should adopt outcome-oriented evidence strategies that couple clinical trial data with pragmatic real-world performance metrics. Demonstrating improvements in adherence, therapy continuity, and clinical workflow efficiency will resonate with value-conscious purchasers. Finally, leaders should explore flexible commercial models, such as subscription services or bundled training and maintenance packages, to lower adoption barriers and align incentives between manufacturers and care providers.

Transparent, multi-method research methodology combining expert interviews, device technical assessments, and workflow analyses to derive actionable operational insights

The research approach combined qualitative expert interviews, device-level technical assessments, and cross-functional workflow analyses to triangulate insights on technology performance and adoption barriers. Primary research included structured discussions with clinicians, biomedical engineers, procurement leaders, and trained caregivers to surface operational pain points and to validate device usability under realistic clinical scenarios. These engagements were complemented by technical reviews of device specifications, sterilization requirements, and materials compatibility to assess implications for reprocessing and lifecycle management.

Secondary research synthesized regulatory guidance, clinical practice standards, and published evidence on device safety and performance, while ensuring careful vetting of sources and an emphasis on peer-reviewed literature and regulatory documentation. Comparative analysis across product platforms focused on design trade-offs-such as disposability versus reusability, material selection, and integration capability-with attention to how these trade-offs manifest in real-world clinical settings. The methodology prioritized reproducibility and transparency, documenting data sources and analytical assumptions to enable readers to trace how insights were derived and to apply them to their specific organizational contexts.

Closing synthesis emphasizing the imperative of interoperable, human-centered delivery systems supported by evidence and supply chain resilience to realize clinical value

In conclusion, patient delivery systems stand at the intersection of device engineering, clinical workflow design, and health system operational strategy. The convergence of smart technologies, shifting care settings, and heightened regulatory expectations is redefining the attributes that matter most to purchasers: connectivity, ease of use, reprocessing clarity, and demonstrable clinical outcomes. Organizations that align product design with real-world clinical workflows, build resilient supply chains, and substantiate claims with post-market evidence will be best positioned to capture durable adoption across diverse care environments.

Moving forward, collaboration across manufacturers, health systems, and regulators will be essential to realize the full potential of emerging delivery technologies and to ensure patient safety as devices take on more active roles in therapy management. By focusing on interoperable designs, human-centered interfaces, and robust evidence strategies, stakeholders can drive adoption pathways that improve patient outcomes while containing operational complexity and cost.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Over Patient Delivery System Market, by Delivery Mode

  • 8.1. Automated
    • 8.1.1. Bolus
    • 8.1.2. Continuous
    • 8.1.3. Intermittent
  • 8.2. Manual
    • 8.2.1. Gravity
    • 8.2.2. Push

9. Over Patient Delivery System Market, by Product Type

  • 9.1. Disposable
    • 9.1.1. Plastic
    • 9.1.2. Silicone
  • 9.2. Reusable
    • 9.2.1. Autoclavable
    • 9.2.2. Nonautoclavable

10. Over Patient Delivery System Market, by Technology

  • 10.1. Patch Pump
    • 10.1.1. Disposable Patch
    • 10.1.2. Reusable Patch
  • 10.2. Tubing
    • 10.2.1. Pvc
    • 10.2.2. Silicone
  • 10.3. Wearable
    • 10.3.1. Non-Smart Wearable
    • 10.3.2. Smart Wearable

11. Over Patient Delivery System Market, by Application

  • 11.1. Anesthesia
  • 11.2. Infusion
  • 11.3. Pain Management

12. Over Patient Delivery System Market, by End User

  • 12.1. Clinics
  • 12.2. Home Care
    • 12.2.1. Patient Self-Administered
    • 12.2.2. Skilled Nursing
  • 12.3. Hospitals
    • 12.3.1. Emergency
    • 12.3.2. General Ward
    • 12.3.3. Icu

13. Over Patient Delivery System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Over Patient Delivery System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Over Patient Delivery System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Over Patient Delivery System Market

17. China Over Patient Delivery System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Acteon Group
  • 18.6. Anthos s.r.l.
  • 18.7. Being Foshan Medical Equipment Co., Ltd.
  • 18.8. Chirana Holding a.s.
  • 18.9. Cingolani S.r.l.
  • 18.10. Confident Dental Equipment Pvt. Ltd.
  • 18.11. Dentsply Sirona Inc.
  • 18.12. Diplomat Dental s.r.o.
  • 18.13. Flight Dental Systems
  • 18.14. Forest Dental Products, Inc.
  • 18.15. Gnatus International Ltda.
  • 18.16. Hican S.A.
  • 18.17. KaVo Dental GmbH
  • 18.18. Marus Dental International
  • 18.19. Mestra Talleres S.L.
  • 18.20. Midmark Corporation
  • 18.21. Planmeca Oy
  • 18.22. Ritter Concept GmbH
  • 18.23. Stern Weber s.r.l.
  • 18.24. Takara Belmont Corporation
  • 18.25. United Medical Equipment Co., Ltd.
  • 18.26. Yoshida Dental Mfg. Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES OVER PATIENT DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY BOLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY BOLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY BOLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GRAVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GRAVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GRAVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PUSH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PUSH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PUSH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOCLAVABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOCLAVABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOCLAVABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NONAUTOCLAVABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NONAUTOCLAVABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NONAUTOCLAVABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE PATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE PATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE PATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE PATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NON-SMART WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NON-SMART WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NON-SMART WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SMART WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SMART WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SMART WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATIENT SELF-ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATIENT SELF-ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATIENT SELF-ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SKILLED NURSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SKILLED NURSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SKILLED NURSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY EMERGENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY EMERGENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GENERAL WARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GENERAL WARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GENERAL WARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ICU, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ICU, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ICU, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 254. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 255. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 256. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 258. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 259. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 261. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 262. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 263. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 266. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 297. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 298. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 300. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 301. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 303. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 304. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 305. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 306. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 307. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 308. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 311. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 312. NATO OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. NATO OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 315. NATO OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 316. NATO OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)